{"title":"Abstract","authors":"","doi":"10.1111/1754-9485.70006","DOIUrl":"https://doi.org/10.1111/1754-9485.70006","url":null,"abstract":"","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"69 S1","pages":"S18-S21"},"PeriodicalIF":1.4,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1754-9485.70006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145196317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Abstract","authors":"","doi":"10.1111/1754-9485.70005","DOIUrl":"https://doi.org/10.1111/1754-9485.70005","url":null,"abstract":"","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"69 S1","pages":"S4-S6"},"PeriodicalIF":1.4,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1754-9485.70005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145196310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Abstract","authors":"","doi":"10.1111/1754-9485.70008","DOIUrl":"https://doi.org/10.1111/1754-9485.70008","url":null,"abstract":"","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"69 S1","pages":"S7-S11"},"PeriodicalIF":1.4,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1754-9485.70008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145196311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Abstract","authors":"","doi":"10.1111/1754-9485.70007","DOIUrl":"https://doi.org/10.1111/1754-9485.70007","url":null,"abstract":"","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"69 S1","pages":"S12-S17"},"PeriodicalIF":1.4,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1754-9485.70007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145196312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p>Allan Ogilvie Langlands AM (1931–2025) was a pioneer, mentor, and one of the most influential figures in Australian radiation oncology. His passing on 28 March 2025 marks the end of an era, but his legacy continues through the generations of clinicians he trained and the countless patients whose lives were touched by his vision.</p><p>Born in Scotland in 1931, Langlands demonstrated early academic brilliance, graduating BSc (Hons) in Physiology in 1953 and MB ChB with Honours from the University of Edinburgh in 1956, where he was awarded the Gold Medal. At that time, the award of Honours MB ChB in Edinburgh—based on performance across the entire course—was rare and often unique in Edinburgh Medical School well into the 1980s, with few, if any, recipients in a given year. Following national service with the Royal Army Medical Corps, he trained in radiotherapy in Edinburgh, joining the MRC Clinical Effects of Radiation Research Unit at the Western General Hospital. His early research focused on leukaemogenesis, thorium exposure, and biological dosimetry—critical topics in a field just beginning to understand radiation's long-term biological impacts.</p><p>From 1969 to 1978, Langlands was Consultant Radiation Oncologist at the Western General and Edinburgh Royal Infirmary, engaging in major UK breast cancer trials. In Edinburgh, he made a lasting impact on breast cancer care across Scotland. At that time, and before his move to Australia, simple mastectomy and radiotherapy—the ‘McWhirter technique’ inherited from Prof Robert McWhirter—were the standard, and Allan did not seek to change this within the 1970s context. He credited much of his early clinical grounding to Professor Robert McWhirter—a giant of British radiotherapy—who instilled in him a scientific rigour and curiosity that shaped the rest of his career.</p><p>In 1978, Langlands accepted the challenge of building a radiation oncology department from the ground up at the new Westmead Hospital in Sydney. It was a pivotal moment for oncology in Australasia. As the first Clinical Professor of Radiation Oncology in the region, he established a comprehensive clinical service and a research and training hub that became a model for other departments. By the time he retired in 1997, Westmead's department housed multiple linear accelerators, brachytherapy services, and more than 70 staff.</p><p>Langlands' clinical passion remained breast cancer, a field in which he made profound international contributions. He led early efforts advocating for breast conservation over mastectomy, emphasising the importance of systemic therapies alongside radiation. He spearheaded multidisciplinary clinics in breast, gynaecological, oesophageal, and haematological malignancies. In Edinburgh, he worked alongside, and often stood up to, influential and powerful surgeons, as there were no trained medical oncologists at the time—only a few physicians dabbling in chemotherapy without formal training and expertise. Despi
Allan Ogilvie Langlands AM(1931-2025)是澳大利亚放射肿瘤学领域的先驱、导师和最有影响力的人物之一。他于2025年3月28日逝世,标志着一个时代的结束,但他的遗产将通过他培养的几代临床医生和无数因他的远见而感动的患者传承下去。朗兰兹1931年出生于苏格兰,早年在学术上表现出色,1953年获得生理学(荣誉)学士学位,1956年获得爱丁堡大学荣誉学士学位,并被授予金质奖章。在那个时候,爱丁堡医学院的荣誉学士学位是基于整个课程的表现而颁发的,这在进入20世纪80年代的爱丁堡医学院是罕见的,而且往往是独一无二的,即使有,在某一年也很少有获得者。在皇家陆军医疗队服役后,他在爱丁堡接受放射治疗培训,加入了西部综合医院MRC放射临床效果研究小组。他早期的研究集中在白血病的发生、钍的暴露和生物剂量学——这是一个刚刚开始了解辐射的长期生物影响的领域的关键主题。从1969年到1978年,Langlands是西部总医院和爱丁堡皇家医院的放射肿瘤学顾问,参与了英国主要的乳腺癌试验。在爱丁堡,他对整个苏格兰的乳腺癌治疗产生了持久的影响。当时,在他搬到澳大利亚之前,简单的乳房切除术和放射治疗——从罗伯特·麦克沃特教授那里继承的“麦克沃特技术”——是标准的,艾伦在20世纪70年代并没有试图改变这一点。他早期的临床基础很大程度上归功于罗伯特·麦克沃特教授——一位英国放射治疗的巨人——他向他灌输了科学的严谨性和好奇心,这影响了他后来的职业生涯。1978年,朗兰兹接受了在悉尼新韦斯特米德医院(Westmead Hospital)从零开始建立一个放射肿瘤科的挑战。这是大洋洲肿瘤学的关键时刻。作为该地区第一位放射肿瘤学临床教授,他建立了全面的临床服务和研究培训中心,成为其他部门的典范。到他1997年退休时,韦斯特米德所在的部门已经拥有多个线性加速器、近距离治疗服务和70多名员工。朗兰兹的临床热情仍然是乳腺癌,他在这个领域做出了深远的国际贡献。他领导了早期倡导乳房保护而不是乳房切除术的努力,强调全身治疗和放疗的重要性。他领导了乳腺、妇科、食道和血液恶性肿瘤的多学科诊所。在爱丁堡,他和有影响力的外科医生一起工作,而且经常与他们对抗,因为当时没有受过训练的肿瘤内科医生——只有少数医生在没有正式培训和专业知识的情况下涉猎化疗。尽管偶尔会发生冲突,但他成功地与外科同事合作进行了早期的随机对照试验,并建立了乳腺癌和肉瘤的多学科诊所。他还亲自建立了一个综合数据库,记录了自20世纪50年代以来在爱丁堡接受治疗的所有乳腺癌患者,并与统计学家吉莉安·克尔(Gillian Kerr)一起进行了细致的随访。这一资源在他移民后得到了很好的更新,为一些重要的出版物做出了贡献,这些出版物表明,在辅助治疗前的时代,乳腺癌在首次治疗后几十年仍然无法治愈。这些合作模式成为了澳大利亚综合护理路径的基础。他发表了160多篇同行评议的文章。他的研究影响了分期、局部控制策略和系统治疗整合,始终以患者为中心。他也是早期倡导更好的结果跟踪、生活质量测量和护理成本效益的人。朗兰兹的国家领导能力令人敬畏。作为当时澳大拉西亚皇家放射学院(RACR)的首席审查员,他帮助制定了下一代放射肿瘤学家的培训课程和考试标准。他是NHMRC 1995年早期乳腺癌国家指南的主要贡献者,并为澳大利亚几个州的癌症服务规划提供咨询。他参与了澳大利亚电离辐射咨询委员会、新南威尔士州癌症委员会和国家乳房研究委员会,帮助确保放射肿瘤学在政策桌上占有一席之地。他强烈主张向医科学生讲授放射肿瘤学。他还在国际环境中提供咨询,包括在巴布亚新几内亚,他支持当地癌症服务的发展。他退休后的日子也同样活跃,在英国国家健康与医学研究委员会临床试验中心担任荣誉职位,并在肿瘤学领域担任医学法律顾问。 在众多荣誉中,他于1996年获得RANZCR金奖,并于2000年获得新南威尔士州癌症委员会专业卓越奖。1997年,他被授予澳大利亚勋章(AM),以表彰他对医学,特别是乳腺癌的贡献。朗兰兹真正的杰出之处在于他将科学的精确性与深刻的人性相结合的能力。他是一位真正意义上的导师——支持我、要求我、鼓舞我。他有一种天赋,可以释放学员的潜力,经常把他们推到舒适区之外。如果他没有得到他想要的答案,他会说:“到目前为止,没有得分”,以鼓励他对眼前的问题进行更深入的思考。他以用冰淇淋打赌来挑战晚辈的临床决策而闻名——这种赌注他很少输。在爱丁堡,他以同样的方式激励和支持实习生、物理学家和其他人,尽管没有冰淇淋赌注,他在离开后很长一段时间里仍被那些专业团体中的许多人怀念和深情地记住。当某件事做得很好时,他会轻描淡写地称赞:“你可以再待一个星期。”如果你犹豫了,你马上就知道了。他周一早上给注册员上的课是传奇般的;如果你迟到了,你肯定知道这件事。他的导师风格既培养了韧性,也培养了知识。他的许多学员后来成为澳大利亚、新西兰和国外主要部门的领导。他培养了一种卓越、正直和循证实践的文化。他还鼓励谦逊和幽默,经常用他的机智化解压力。在2006年的《乳房》回顾中,他回顾了放射治疗从钴机到适形技术的转变,并超越了[1]。他对未来的进步表示乐观,但警告不要自满、技术过度使用和商业影响。退休后,他继续写作,他的作品仍然是实习生和临床医生的必读读物。朗兰兹的工作超越了诊所和演讲厅。他与卫生经济学家、流行病学家和消费者权益倡导者密切合作,为有关医疗保健价值、资源分配和幸存者的全国性讨论做出了贡献。几十年来,他的广阔视野帮助塑造了澳大利亚的癌症控制议程。据他的家人说,他支持米德洛锡安之心足球俱乐部,小时候和父亲一起观看泰纳卡斯尔的比赛,并在他的一生中继续关注他们的进步。他也喜欢关注英超联赛。此外,他对橄榄球联盟有着毕生的热情,尤其是在苏格兰,并且会在访问期间参加在默里菲尔德举行的国际比赛——人们怀疑他是否选择了同样的日期。朗兰兹身后留下了他的孩子吉莉安(Gillian)和科林(Colin),以及孙子帕特里夏(Patricia)和柯克(Kirk)。他深爱的妻子海伦于2018年去世。20世纪50年代中期,他在RAMC服役期间,被派往新加坡的英国军事医院,两人相识,这种伙伴关系持续了几十年。他在澳大利亚和苏格兰的同事和前学员都记得他是放射肿瘤学领域的杰出人物。尽管他在澳大利亚的职业生涯长达数十年,巩固了他作为该领域领导者的地位,但朗兰兹在苏格兰也留下了持久的遗产,尽管时间较短。在那里,他为自己的临床方法奠定了基础,指导了未来的领导者,开发了服务,并影响了癌症治疗。他的性格——有时易怒,经常对抗,但总是有原则——与他的成就密不可分,并且仍然是世界两岸同事对他的记忆的核心。在他的葬礼上,他的女儿反映说,他之所以决定移民到澳大利亚,是因为在麦克沃特教授退休后,他没有被任命为爱丁堡放射治疗中心的主席,这在当时的爱丁堡被广泛认为是一个结果。对这个家族来说,这是一个重大的剧变,但苏格兰的损失变成了澳大利亚和新西兰的收获。他的影响已经融入了这个国家放射肿瘤学的DNA中。Boyages:构思,写作-原稿。罗杰:写作-评论和编辑。K. W.蒂弗:写作——原稿。V.埃亨:构思,写作-原稿。作者声明无利益冲突。数据共享不适用于本文,因为在当前研究期间没有生成或分析数据集。
{"title":"Allan O. Langlands: A Giant of Radiation Oncology in Australia","authors":"J. Boyages, A. Rodger, K. W. Tiver, V. Ahern","doi":"10.1111/1754-9485.70027","DOIUrl":"https://doi.org/10.1111/1754-9485.70027","url":null,"abstract":"<p>Allan Ogilvie Langlands AM (1931–2025) was a pioneer, mentor, and one of the most influential figures in Australian radiation oncology. His passing on 28 March 2025 marks the end of an era, but his legacy continues through the generations of clinicians he trained and the countless patients whose lives were touched by his vision.</p><p>Born in Scotland in 1931, Langlands demonstrated early academic brilliance, graduating BSc (Hons) in Physiology in 1953 and MB ChB with Honours from the University of Edinburgh in 1956, where he was awarded the Gold Medal. At that time, the award of Honours MB ChB in Edinburgh—based on performance across the entire course—was rare and often unique in Edinburgh Medical School well into the 1980s, with few, if any, recipients in a given year. Following national service with the Royal Army Medical Corps, he trained in radiotherapy in Edinburgh, joining the MRC Clinical Effects of Radiation Research Unit at the Western General Hospital. His early research focused on leukaemogenesis, thorium exposure, and biological dosimetry—critical topics in a field just beginning to understand radiation's long-term biological impacts.</p><p>From 1969 to 1978, Langlands was Consultant Radiation Oncologist at the Western General and Edinburgh Royal Infirmary, engaging in major UK breast cancer trials. In Edinburgh, he made a lasting impact on breast cancer care across Scotland. At that time, and before his move to Australia, simple mastectomy and radiotherapy—the ‘McWhirter technique’ inherited from Prof Robert McWhirter—were the standard, and Allan did not seek to change this within the 1970s context. He credited much of his early clinical grounding to Professor Robert McWhirter—a giant of British radiotherapy—who instilled in him a scientific rigour and curiosity that shaped the rest of his career.</p><p>In 1978, Langlands accepted the challenge of building a radiation oncology department from the ground up at the new Westmead Hospital in Sydney. It was a pivotal moment for oncology in Australasia. As the first Clinical Professor of Radiation Oncology in the region, he established a comprehensive clinical service and a research and training hub that became a model for other departments. By the time he retired in 1997, Westmead's department housed multiple linear accelerators, brachytherapy services, and more than 70 staff.</p><p>Langlands' clinical passion remained breast cancer, a field in which he made profound international contributions. He led early efforts advocating for breast conservation over mastectomy, emphasising the importance of systemic therapies alongside radiation. He spearheaded multidisciplinary clinics in breast, gynaecological, oesophageal, and haematological malignancies. In Edinburgh, he worked alongside, and often stood up to, influential and powerful surgeons, as there were no trained medical oncologists at the time—only a few physicians dabbling in chemotherapy without formal training and expertise. Despi","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"69 8","pages":"787-789"},"PeriodicalIF":1.4,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1754-9485.70027","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145659708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asare Augustine Amoafo, Diederick Willem De Boo, Matthew William Lukies
Interventional Radiology (IR) is a relatively young specialty that has experienced rapid development since Charles Dotter performed the first percutaneous transluminal angioplasty in 1964. Since then, IR has expanded to include a diverse array of minimally invasive image-guided procedures. It was the same Charles Dotter who early on recognized that the Interventional Radiologist must be involved in patient care as a true clinician, not just a skilled mechanic. However, outpatient and periprocedural clinical patient management by IR has remained underdeveloped when compared to the significant procedural advancements seen over the past four decades. We present local Australian health service data reinforcing the value of formal outpatient clinics in delivering adequate patient counselling, improving consent rates prior to the procedure day, and decreasing costly day-of-procedure cancellations and reschedulling.
{"title":"Formal Outpatient Clinics in Interventional Radiology: An Essential Component of Modern Practice","authors":"Asare Augustine Amoafo, Diederick Willem De Boo, Matthew William Lukies","doi":"10.1111/1754-9485.70028","DOIUrl":"10.1111/1754-9485.70028","url":null,"abstract":"<p>Interventional Radiology (IR) is a relatively young specialty that has experienced rapid development since Charles Dotter performed the first percutaneous transluminal angioplasty in 1964. Since then, IR has expanded to include a diverse array of minimally invasive image-guided procedures. It was the same Charles Dotter who early on recognized that the Interventional Radiologist must be involved in patient care as a true clinician, not just a skilled mechanic. However, outpatient and periprocedural clinical patient management by IR has remained underdeveloped when compared to the significant procedural advancements seen over the past four decades. We present local Australian health service data reinforcing the value of formal outpatient clinics in delivering adequate patient counselling, improving consent rates prior to the procedure day, and decreasing costly day-of-procedure cancellations and reschedulling.</p>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"69 8","pages":"825-828"},"PeriodicalIF":1.4,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1754-9485.70028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jack Edward Liu, Lisa Milner, Behnam Shaygi, Michael Stewart, Anousha Yazdabadi, Julian Maingard, Hong Kuan Kok, Numan Kutaiba, Christen D. Barras, Paul Maria Parizel, Hamed Asadi